Morning Overview on MSN
Discovery could one day reverse osteoporosis, scientists say
For decades, osteoporosis has meant a slow, one way slide toward fragile bones and fracture risk, managed but rarely truly ...
FDA qualification of Total Hip BMD as a validated surrogate endpoint for novel osteoporosis drug development further bolsters Entera's July 2025 ...
The FDA greenlights treatment-related changes in bone mineral density as a surrogate endpoint in anti-osteoporosis drug trials in postmenopausal women.
6d
FNIH Announces FDA Qualification of First Surrogate Endpoint for Use in Osteoporosis Clinical Trials
The Foundation for the National Institutes of Health (FNIH) announces that the Food and Drug Administration (FDA) has qualified the treatment-related change in hip bone mineral density (BMD) as a ...
A systematic review and meta-analysis has found that bisphosphonates—medicines commonly used to treat osteoporosis—may offer ...
Bone is living tissue, and is constantly being renewed and replaced in the body. 0steoporosis (thinning bones) comes about when bone tissue is broken down faster than it is formed. When this happens, ...
The International Osteoporosis Foundation (IOF) and the Asia Pacific Consortium on Osteoporosis (APCO) have today launched The APCO-IOF Asia Pacific Regional Audit: Epidemiology, Costs and Burden of ...
But new research suggests that a simple blood test may be able to predict osteoporosis risk, allowing doctors to intervene ...
CHICAGO (Reuters) - A once-a-day pill helped completely rebuild bone in rodents with severe osteoporosis, a finding that could lead to a new class of drugs to treat the brittle-bone disease in humans, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback